Brown Michael S

Director

1 company

Average

Trades Analyzed

12M Win Rate

20.0%

Avg 3M Return

-5.5%

Avg 12M Return

-4.7%

Brown Michael S is a Director at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 41 sells.

Estimated insider holdings value: $1.0M based on current market prices.

Holdings by Company

REGNJan 2, 2026

Current Shares1.7K

Value$1.04M

Net Activity-75,060

Bought: 0Sold: 75.1K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 13, 2021	REGN Regeneron Pharmaceuticals, Inc.	Director	Sale+OE	9,704	$648.16	$6,289,792.38	-6.9%	+3.2%	+9.7%
Aug 9, 2021	REGN Regeneron Pharmaceuticals, Inc.	Director	Sell	1,687	$612.38	$1,033,085.06	-18.0%	+1.4%	+1.3%
Jun 25, 2021	REGN Regeneron Pharmaceuticals, Inc.	Director	Sale+OE	2,084	$549.00	$1,144,116.00	-70.1%	+17.4%	+11.3%
Jun 14, 2021	REGN Regeneron Pharmaceuticals, Inc.	Director	Sale+OE	1,700	$525.00	$892,500.00	-65.6%	+20.9%	+3.7%
Jan 25, 2021	REGN Regeneron Pharmaceuticals, Inc.	Director	Sale+OE	2,480	$554.32	$1,374,713.60	-73.6%	-	-
Sep 22, 2020	REGN Regeneron Pharmaceuticals, Inc.	Director	Sale+OE	6,090	$552.36	$3,363,872.40	-37.9%	-	-
Jul 1, 2020	REGN Regeneron Pharmaceuticals, Inc.	Director	Sale+OE	3,613	$607.62	$2,195,341.86	-13.6%	-	-
May 7, 2020	REGN Regeneron Pharmaceuticals, Inc.	Director	Sale+OE	1,809	$562.00	$1,016,658.00	-73.8%	-	-
Feb 24, 2020	REGN Regeneron Pharmaceuticals, Inc.	Director	Sale+OE	2,000	$419.00	$838,001.32	-60.1%	-	-
Dec 13, 2019	REGN Regeneron Pharmaceuticals, Inc.	Director	Sale+OE	4,000	$373.99	$1,495,968.35	-41.9%	-	-